Trial Outcomes & Findings for Toric Contact Lens Digital Performance and Comfort Study (NCT NCT04772560)
NCT ID: NCT04772560
Last Updated: 2022-03-10
Results Overview
High contrast LogMAR visual acuity was assessed at 40 cm using the M\&S Clinical Trial Suite system (Niles, Illinois, USA). The system was calibrated according to the manufacturer's directions every day, prior to use. Testing was performed binocularly 10+/-2 days after each intervention. The test started at 20/60 and continued until three letters were missed on a line.
COMPLETED
NA
30 participants
10 +/- 2 days
2022-03-10
Participant Flow
30 participants were screened for eligibility between March and December 2021
23 of 30 participants were randomized. Of those not randomized, 7 did not meet inclusion criteria.
Participant milestones
| Measure |
Toric Then Spherical
Participants who received toric contact lenses first and spherical lenses after 10 days
|
Spherical Then Toric
Participants who received spherical contact lenses first and toric lenses after 10 days
|
|---|---|---|
|
Overall Study
STARTED
|
11
|
12
|
|
Overall Study
COMPLETED
|
11
|
12
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Toric Contact Lens Digital Performance and Comfort Study
Baseline characteristics by cohort
| Measure |
All Participants
n=23 Participants
23 participants who had completed the study
|
|---|---|
|
Age, Continuous
|
24.4 years
STANDARD_DEVIATION 4.2 • n=5 Participants
|
|
Sex: Female, Male
Female
|
17 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
6 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
9 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
14 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
8 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
3 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
11 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
23 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 10 +/- 2 daysHigh contrast LogMAR visual acuity was assessed at 40 cm using the M\&S Clinical Trial Suite system (Niles, Illinois, USA). The system was calibrated according to the manufacturer's directions every day, prior to use. Testing was performed binocularly 10+/-2 days after each intervention. The test started at 20/60 and continued until three letters were missed on a line.
Outcome measures
| Measure |
All Participants
n=23 Participants
23 participants who had completed the study
|
|---|---|
|
Near Visual LogMAR Acuity
Toric CL
|
-0.10 LogMAR
Standard Error 0.02
|
|
Near Visual LogMAR Acuity
Spherical CL
|
-0.03 LogMAR
Standard Error 0.21
|
PRIMARY outcome
Timeframe: 10 +/- 2 daysDynamic VA was determined using a custom-made iPad application. The subject was instructed to hold the iPad at 40cm and presented with a Landolt C surrounded by crowding bars for 0.3s each, starting from 0.5 LogMAR and progressing to smaller sizes using a staircase threshold method. Testing was performed binocularly 10+/-2 days after each intervention
Outcome measures
| Measure |
All Participants
n=23 Participants
23 participants who had completed the study
|
|---|---|
|
Dynamic Visual Acuity
Toric CL
|
0.04 LogMAR
Standard Error 0.02
|
|
Dynamic Visual Acuity
Spherical CL
|
0.11 LogMAR
Standard Error 0.02
|
Adverse Events
Toric Contact Lens Wear
Spherical Contact Lens Wear
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Toric Contact Lens Wear
n=23 participants at risk
23 participants had completed the study
|
Spherical Contact Lens Wear
n=23 participants at risk
23 participants had completed the study
|
|---|---|---|
|
Eye disorders
Corneal staining
|
13.0%
3/23 • Number of events 3 • 10 ± 2 days for each intervention
AE information was collected at each study visit
|
0.00%
0/23 • 10 ± 2 days for each intervention
AE information was collected at each study visit
|
|
Eye disorders
Hordeolum
|
4.3%
1/23 • Number of events 1 • 10 ± 2 days for each intervention
AE information was collected at each study visit
|
0.00%
0/23 • 10 ± 2 days for each intervention
AE information was collected at each study visit
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place